MIRALOCK Trademark
MIRALOCK is a USPTO trademark filed by Mirador Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | MIRALOCK |
|---|---|
| Serial Number | 99605203 |
| Status | Pending |
| Filing Date | 2026-01-20 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Mirador Therapeutics, Inc. |
| Attorney of Record | Brent D. Sokol |
| Prosecution Events | 5 |
| Latest Event | CHAN on 2026-04-02 |
Goods & Services
Class 001: Chemical substances, chemical materials and chemical preparations for scientific purposes; Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; Class 005: Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents; Class 042: Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics